During the past decade, Universidad Autonoma de Guadalajara conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidad Autonoma de Guadalajara" #1 collaborator was "Bausch Health Americas, Inc." with 2 trials as a collaborator and "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universidad Autonoma de Guadalajara" are "Diarrhea" (2 trials) and "Travelers' Diarrhea" (1 trials). Many other conditions were trialed in "Universidad Autonoma de Guadalajara" in a lesser frequency.

Most popular intervention types in "Universidad Autonoma de Guadalajara" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Rifaximin and loperamide" (1 trials), "loperamide-simethicone" (1 trials), "matching placebo" (1 trials) and "rifaximin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidad Autonoma de Guadalajara" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universidad Autonoma de Guadalajara". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universidad Autonoma de Guadalajara, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidad Autonoma de Guadalajara, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".